EKEMEN, S. Et Al. 2024. The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors. BREAST CANCER-TARGETS AND THERAPY , vol.16 , 1-13.

EKEMEN, S., Bilir, E., Soultan, H. E. A., Zafar, S., DEMİR, F., Tabandeh, B., ... TOPRAK, S.(2024). The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors. BREAST CANCER-TARGETS AND THERAPY , vol.16, 1-13.

EKEMEN, SÜHEYLA Et Al. "The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors," BREAST CANCER-TARGETS AND THERAPY , vol.16, 1-13, 2024

EKEMEN, SÜHEYLA Et Al. "The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors." BREAST CANCER-TARGETS AND THERAPY , vol.16, pp.1-13, 2024

EKEMEN, S. Et Al. (2024) . "The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors." BREAST CANCER-TARGETS AND THERAPY , vol.16, pp.1-13.

@article{article, author={SÜHEYLA EKEMEN Et Al. }, title={The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors}, journal={BREAST CANCER-TARGETS AND THERAPY}, year=2024, pages={1-13} }